General MM,      & 1 more

The CHMP recommends daratumumab as front-line treatment

Patients eligible for transplant,      & 2 more

Galinpepimut-S granted FDA orphan drug designation

Relapsed/refractory patients

Orphan drug designation granted to PT-112